There’s a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Brinker International (EAT – Research Report), Xponential Fitness (XPOF – Research Report) and Immuneering (IMRX – Research Report) with bullish sentiments.
Brinker International (EAT)
Jefferies analyst Alexander Slagle maintained a Buy rating on Brinker International today and set a price target of $78.00. The company’s shares closed last Wednesday at $48.10.
Slagle has an average return of
According to TipRanks.com, Slagle is ranked #1942 out of 7688 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Brinker International with a $67.26 average price target.
See the top stocks recommended by analysts >>
Xponential Fitness (XPOF)
In a report released yesterday, Randal Konik from Jefferies maintained a Buy rating on Xponential Fitness, with a price target of $18.00. The company’s shares closed last Wednesday at $13.69, close to its 52-week high of $14.29.
According to TipRanks.com, Konik is a 5-star analyst with an average return of
Currently, the analyst consensus on Xponential Fitness is a Strong Buy with an average price target of $16.69.
Immuneering (IMRX)
Jefferies analyst Michael Yee maintained a Buy rating on Immuneering yesterday and set a price target of $50.00. The company’s shares closed last Wednesday at $23.02.
According to TipRanks.com, Yee is a 4-star analyst with an average return of
Immuneering has an analyst consensus of Strong Buy, with a price target consensus of $43.67.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EAT:
- Plug Power Partners With Airflow to Develop Hydrogen-Based Propulsion System; Shares Pop 13%
- Noble Financial Reaffirms Their Buy Rating on Great Lakes Dredge & Dock (GLDD)
- Industrial Tech Acquisitions (ARBE) Receives a Buy from R.F. Lafferty
- Noble Financial Thinks Esports Entertainment Group’s Stock is Going to Recover
- OrthoPediatrics Expects Q3 Revenue Below Street Estimate; Shares Dip 2.4%